5-fluorouracil induced cardiotoxicity: Review of the literature

Michael F. Sorrentino, Jiwon Kim, Andrew E. Foderaro, Alexander G. Truesdell
DOI: 10.5603/CJ.2012.0084
·
Cardiol J 2012;19(5):453-457.

open access

Vol 19, No 5 (2012)
Review articles
Published online: 2012-10-06
Submitted: 2013-01-24

Abstract

5-fluorouracil (5-FU) is a key chemotherapeutic agent in the treatment of many gastrointestinal tract adenocarcinomas. Despite its proven therapeutic efficacy, 5-FU also possesses several undesired cardiac toxicities, including coronary vasospasm, coronary thrombosis, cardiomyopathy, and sudden cardiac death. This review addresses the incidence, mechanisms of action, clinical presentation, risk stratification, and management of 5-FU associated cardiotoxicity; it also highlights the importance of careful pre-administration cardiac risk stratification and close monitoring during and after drug administration. (Cardiol J 2012; 19, 5: 453-458)

Keywords

5-fluorouracil; acute coronary syndrome; cardiotoxicity

About this article
Title

5-fluorouracil induced cardiotoxicity: Review of the literature

Journal

Cardiology Journal

Issue

Vol 19, No 5 (2012)

Pages

453-457

Published online

2012-10-06

DOI

10.5603/CJ.2012.0084

Bibliographic record

Cardiol J 2012;19(5):453-457.

Keywords

5-fluorouracil
acute coronary syndrome
cardiotoxicity

Authors

Michael F. Sorrentino
Jiwon Kim
Andrew E. Foderaro
Alexander G. Truesdell

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl